Reveal-Dx is a Seattle-based software company whose vision is to dramatically improve lung cancer outcomes by delivering the most advanced radiomics and AI-enabled, lung cancer decision support software. Formerly Mindshare Medical. Investor since 2016.
Location: United States, Washington, Seattle
Employees: 1-10
Founded date: 2014
Investors 1
| Date | Name | Website |
| 10.03.2022 | Westway Ca... | westwaycap... |
Mentions in press and media 3
| Date | Title | Description |
| 23.10.2025 | How AI Is Poised to Cut Lung Cancer Mortality by Accelerating Early Detection | Chris Wood, CEO of Reveal Dx With lung cancer being the leading cause of cancer-related deaths worldwide, advancements in AI-powered healthcare technology are offering newfound hope. Over the span of the next few decades, AI is poised to re... |
| 02.05.2024 | contextflow targets early lung cancer detection by augmenting ADVANCE Chest CT with malignancy scoring from RevealDX | Malignancy Scoring can reduce false positives and detect lung cancer up to one year sooner. contextflow and RevealDx are working to improve lung cancer screening Chest CT experts contextflow GmbH have released a new version of their compreh... |
| - | Reveal-Dx | “Reveal DX | Informing Precision Medicine” |